NEW BRUNSWICK, N.J.,
April 24, 2019 /PRNewswire/
-- Johnson & Johnson (NYSE: JNJ) will host a review of its
Pharmaceutical businesses for the investment community beginning at
8:30 a.m. (Eastern Time) on
Wednesday, May 15, 2019 at the Hyatt Regency Hotel in
New Brunswick, New Jersey, and
ending at approximately 2:30 p.m.
Alex Gorsky, Chairman and Chief
Executive Officer will provide opening remarks. The event
will be hosted by Jennifer Taubert,
Executive Vice President, Worldwide Chairman, Pharmaceuticals; and
Mathai Mammen, M.D., Ph.D. Global
Head, Janssen Research & Development. The meeting will
feature presentations from the therapeutic area leaders within the
Janssen Research & Development organization, which will be
followed by Q&A sessions. In addition, Joe Wolk, Executive Vice President, Chief
Financial Officer will provide closing remarks followed by a
Q&A session with members of the Executive
Committee.
The agenda for the day will be posted on the Investor Relations
website on May 10th.
Investors and other interested parties may access this meeting
by visiting the Company's website at www.investor.jnj.com for a
simultaneous webcast of the presentations.
A replay will be available shortly after the live webcast.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-to-host-pharmaceutical-business-review-300837920.html
SOURCE Johnson & Johnson